UBS AM’s Kailera Therapeutics KLRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$322K Buy
+28,218
New +$477K ﹤0.01% 2897

Other funds holding KLRA

UBS AM's KLRA Position: Q3 2026 in Review

UBS AM opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 28,218 shares worth $322K. The stake represents ﹤0.01% of the portfolio and ranks #2897 among its holdings.

132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • UBS AM held 28,218 shares of Kailera Therapeutics worth $322K as of Q3 2026.
  • Kailera Therapeutics was a new UBS AM position in Q3 2026.
  • Kailera Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #2897 holding.
  • 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.